Authors


KRISTINE LA, PHARMD CANDIDATE 2018

Latest:

Exciting New Hepatitis C Therapies Approved at the End of 2017

Treatment-experienced patients still have some good options.



MONICA V. MAHONEY, PHARMD, BCPS AQ-ID, BCIDP*

Latest:

Regdanvimab—A New Attack of the (Mono)Clones

A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.



Samara Rosenfeld

Latest:

Obesity Medicine Doctor Turns COVID-19 Infection into Learning Experience

The story of an early-infected US physician who launched a non-profit, participated in trials, and guided her peers after overcoming infection.


Sarah E. Perez, PharmD

Latest:

Antiretroviral Stewardship: The Time is Now

In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.


Kari Oakes, PA-C

Latest:

Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B

Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.


Lorraine L. Janeczko, MPH

Latest:

Ocular Syphilis and Cytomegalovirus Retinitis Have Different Immunologic Profiles

Researchers have found that individuals with cytomegalovirus retinitis have a more advanced HIV infection than individuals with ocular syphilis.


Clarence D. Moore, PharmD, BCPS

Latest:

Decongestants and Hypertension: Dangerous Together

Pharmacists can play an important role in managing the use of these medications in patients, particularly those with high blood pressure.


NICOLE COFFIN, MA

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


Davey James

Latest:

Gene Therapy Shows Promise in Neutralizing HIV

Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.


Conan MacDougall, PharmD, MAS

Latest:

Intraseasonal Influenza Vaccine Effectiveness Waning: Threading the Needle for Immunity

Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.


Samar Mahmoud, MS

Latest:

Gardnerella Bacteremia Reported in HIV-Positive Male

Investigators from the University of California San Diego Medical School report on the first case of Gardnerella bacteremia in an HIV-positive male following the placement of a urinary catheter.


Noel Abastillas

Latest:

Letters to Doctors Help Fight Over-Prescription of Antibiotics

A new trial conducted in England has discovered a cost-effective way to reduce the overprescribing of antibiotics by general practitioners (GPs).



KRUTIKA KUPPALLI, MD

Latest:

What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?




Samuel L. Aitken, PharmD, MPH

Latest:

Current and Potential Treatment Options for Stenotrophomonas maltophilia Infections

We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.


Susan A. Innis, MD

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.



Alexander Kantorovich, PharmD, BCPS

Latest:

Community Acquired Pneumonia and the Role of Adjunctive Corticosteroids

Antibiotics are the mainstay treatment for CAP; however, the additive role of corticosteroids is continually being debated.


BENJAMIN BLUEN, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Pattie Jakel, MN, RN, AOCN

Latest:

Evidence-Based Intervention Reduces C. diff Rates in Adults With Cancer

SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.


By Erin K. McCreary, PharmD, BCPS BCIDP*

Latest:

Are Two Antibiotics Better Than One?

A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.


Patrick Ayscue, DVM

Latest:

The Ripple Effect of Climate Change on Epidemic Risk

While rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.


KATY CAPERS, MA

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


PAUL LEONE, MD

Latest:

A Case of Disseminated Nocardia farcinica Presenting as Fever of Unknown Origin in a Transplant Patient

Outcomes in disseminated nocardiosis are variable and depend on patient factors.



Hilary C. Kelly, MPH

Latest:

Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.

© 2024 MJH Life Sciences

All rights reserved.